Enterprise Value
69.94M
Cash
10.86M
Avg Qtr Burn
-6.75M
Short % of Float
1.34%
Insider Ownership
25.27%
Institutional Own.
8.88%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
INB-100 Details Leukemia, Blood cancer, Cancer | Phase 2 Data readout | |
INB-400 Details Glioblastoma, Cancer | Phase 2 Initiation | |
INB-200 Details Glioblastoma | Phase 1 Update |